Resources
Legislative Testimonies
As advocates for the elimination of health disparities and experts on policy factors that impact drug pricing and access, JHDAAI faculty are often sought as expert sources for testimony in legislative chambers at the State and Federal levels.
Federal Testimonies
| Legislative Proposals to Support Patients with Rare Diseases Hearing before the Health Subcommittee of the House Energy & Commerce Committee (February 29, 2024) Testimony by Jeromie Ballreich | Website Link |
| Examining Chronic Drug Shortages in the United States Hearing of the House Ways & Means Committee (February 6, 2024) Testimony by Jeromie Ballreich | Website Link |
| Lower Drug Costs Now: Expanding Access To Affordable Health Care Before the House Committee On Education And Labor Subcommittee On Health, Employment, Labor And Pensions (May 5, 2021) Testimony by Mariana Socal | |
| Making Prescription Drugs More Affordable: Legislation to Negotiate a Better Deal for Americans Before the House Committee on Energy and Commerce Subcommittee on Health, Employment, Labor and Pensions (September 26, 2019) Testimony by Mariana Socal |
State Testimonies
| Comments on HB1397, the Insulin Cost Reduction Act Before The Maryland General Assembly Health And Government Operations Committee (March 15, 2022) Testimony by Mariana Socal |
Interviews & Appearances
| The Biden Administration's Medicare Drug Price Negotiation Plan C-SPAN Interview with Mariana Socal (August 31, 2023) | Video |
| The Global Supply Chain for Generic Drugs Health Affairs Podcast with Mariana Socal (March 21, 2023) | Video |
| The Far-Reaching Impacts of Drug Shortages Affecting Cancer Treatments Public Health on Call Podcast with Mariana Socal (July 7, 2023) | Video |
Access past testimonies here or contact us to connect with an expert directly.
Visualize Data in Our JHDAAI Chartbooks
JHDAAI periodically publishes “chartbooks” to provide graphical representations of the latest research and data outcomes for policymakers, media, researchers, and the public.